Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aratana Theraptcs (PETX)

Aratana Theraptcs (PETX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aratana Theraptcs 11400 TOMAHAWK CREEK PARKWAY SUITE 340 LEAWOOD KS 66211 USA

P: 913-353-1000 F: 913-904-9641

Description:

Aratana Therapeutics Inc. is a biopharmaceutical company for animals. The Company is developing compounds for the pet health market, including a non-COXIB analgesic for treating pain, an appetite-stimulating molecule for inappetence and licensed non-opioid local anesthetic for treating post-operative pain. It operates in the United States and Europe. Aratana Therapeutics Inc. is headquartered in Kansas City, Kansas.

Key Statistics

Overview:

Market Capitalization, $K 240,928
Shares Outstanding, K 48,969
Annual Sales, $ 35,410 K
Annual Net Income, $ -14,720 K
Last Quarter Sales, $ 7,360 K
Last Quarter Net Income, $ -6,790 K
60-Month Beta 1.40
% of Insider Shareholders 5.30%
% of Institutional Shareholders 65.00%
Float, K 46,374
% Float 94.70%

Growth:

1-Year Return 11.31%
3-Year Return -24.54%
5-Year Return -60.48%
5-Year Revenue Growth 29,408.33%
5-Year Earnings Growth 71.43%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/01/19
Earnings Per Share ttm -0.27
EPS Growth vs. Prev Qtr 22.22%
EPS Growth vs. Prev Year 26.32%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

PETX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -12.10
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -13.00
Return-on-Assets (Before Tax) -10.83
Profit Margin % -41.57
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 6.82
Price/Cash Flow N/A
Price/Book 2.50
Book Value/Share 1.96
Interest Coverage -3.34
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar